Alpha-synuclein involvement in hippocampal synaptic plasticity: role of NO, cGMP, cGK and CaMKII

Eur J Neurosci. 2007 Jun;25(12):3583-96. doi: 10.1111/j.1460-9568.2007.05569.x.

Abstract

Synaptic plasticity involves a series of coordinate changes occurring both pre- and postsynaptically, of which alpha-synuclein is an integral part. We have investigated on mouse primary hippocampal neurons in culture whether redistribution of alpha-synuclein during plasticity involves retrograde signaling activation through nitric oxide (NO), cGMP, cGMP-dependent protein kinase (cGK) and calmodulin-dependent protein kinase II. We have found that deletion of the alpha-synuclein gene blocks both the long-lasting enhancement of evoked and miniature transmitter release and the increase in the number of functional presynaptic boutons evoked through the NO donor, DEA/NO, and the cGMP analog, 8-Br-cGMP. In agreement with these findings both DEA/NO and 8-Br-cGMP were capable of producing a long-lasting increase in number of clusters for alpha-synuclein through activation of soluble guanylyl cyclase, cGK and calcium/calmodulin-dependent protein kinase IIalpha. Thus, our results suggest that NO, cGMP, GMP-dependent protein kinase and calmodulin-dependent protein kinase II play a key role in the redistribution of alpha-synuclein during plasticity.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Animals, Newborn
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2
  • Calcium-Calmodulin-Dependent Protein Kinases / physiology*
  • Cell Count
  • Cells, Cultured
  • Cyclic GMP / physiology*
  • Cyclic GMP-Dependent Protein Kinases / physiology*
  • Drug Interactions
  • Enzyme Inhibitors / pharmacology
  • Glutamic Acid / pharmacology
  • Hippocampus / cytology*
  • Mice
  • Mice, Knockout
  • Neuronal Plasticity / drug effects
  • Neuronal Plasticity / physiology*
  • Neurons / drug effects
  • Neurons / physiology
  • Nitric Oxide / physiology*
  • Patch-Clamp Techniques / methods
  • Synapses / drug effects
  • Synapses / physiology
  • alpha-Synuclein / deficiency
  • alpha-Synuclein / metabolism*

Substances

  • Enzyme Inhibitors
  • alpha-Synuclein
  • Nitric Oxide
  • Glutamic Acid
  • Cyclic GMP-Dependent Protein Kinases
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2
  • Calcium-Calmodulin-Dependent Protein Kinases
  • Camk2a protein, mouse
  • Cyclic GMP